Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06921486 |
| Consolidated Lead Sponsor | Shanghai Yinnuo Pharmaceutical Technology Co |
| Therapeutic Condition Cohort | Endocrinology, Obesity, and Metabolic |
| Clinical Trial Phase | Phase II/III |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 1,003 participants (ACTUAL) |
| Registered Start Date | 2025-03-31 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Beijing Friendship Hospital , Capital Medical University | Beijing, China | Open Hospital Dossier -> |
| Beijing Tsinghua Changgung Hospital | Beijing, China | Open Hospital Dossier -> |
| Peking University First Hospital | Beijing, China | Open Hospital Dossier -> |
| Nanfang Hospital, Southern Medical University | Guangzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Endocrinology, Obesity, and Metabolic Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.